TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 156 filers reported holding TRANSENTERIX INC in Q3 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $89,000 | -60.3% | 144,391 | -12.3% | 0.00% | – |
| Q2 2019 | $224,000 | -43.3% | 164,616 | -0.8% | 0.00% | -100.0% |
| Q1 2019 | $395,000 | +49.1% | 165,950 | +41.3% | 0.00% | – |
| Q4 2018 | $265,000 | -33.9% | 117,420 | +69.8% | 0.00% | -100.0% |
| Q3 2018 | $401,000 | +25.3% | 69,166 | -5.9% | 0.00% | 0.0% |
| Q2 2018 | $320,000 | +154.0% | 73,466 | -0.7% | 0.00% | – |
| Q1 2018 | $126,000 | -0.8% | 73,966 | +12.6% | 0.00% | – |
| Q4 2017 | $127,000 | +33.7% | 65,666 | -1.2% | 0.00% | – |
| Q3 2017 | $95,000 | +265.4% | 66,467 | +82.8% | 0.00% | – |
| Q2 2017 | $26,000 | -3.7% | 36,363 | +61.5% | 0.00% | – |
| Q1 2017 | $27,000 | +22.7% | 22,513 | +34.7% | 0.00% | – |
| Q4 2016 | $22,000 | +10.0% | 16,713 | +38.1% | 0.00% | – |
| Q3 2016 | $20,000 | -4.8% | 12,100 | -28.8% | 0.00% | – |
| Q2 2016 | $21,000 | -55.3% | 16,985 | +53.9% | 0.00% | – |
| Q1 2016 | $47,000 | – | 11,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
| StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
| Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
| Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
| BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
| ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |